NCT03215264 2023-11-09
To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
Clinical Trials
4 trialsNCT02232243 2021-06-28
HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors
University of Kentucky
Phase 1 Completed
NCT01687179 2018-10-11
SAIL
Brigham and Women's Hospital
Phase 1 Completed
NCT01026844 2017-01-30
Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC)
Massachusetts General Hospital
Phase 1 Terminated